Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

被引：0
|
作者：
Patricia Pozo-Rosich
Messoud Ashina
Stewart J. Tepper
Sidsel Jensen
Line Pickering Boserup
Mette Krog Josiassen
Bjørn Sperling
机构：
[1] Headache Unit,Neurology Department
[2] Hospital Universitari Vall d’Hebron,Headache Research Group, Department of Medicine
[3] Vall d’Hebron Institute of Research,Department of Neurology, Danish Headache Center
[4] Universitat Autonoma de Barcelona,Department of Clinical Medicine
[5] Copenhagen University Hospital–Rigshospitalet,undefined
[6] University of Copenhagen,undefined
[7] New England Institute for Neurology and Headache,undefined
[8] H. Lundbeck A/S,undefined
来源：
Neurology and Therapy | 2024年 / 13卷
关键词：
Anti-CGRP; Eptinezumab; Migraine; Preventive treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 353
页数：14
相关论文
共 50 条
  • [1] Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
    Pozo-Rosich, Patricia
    Ashina, Messoud
    Tepper, Stewart J.
    Jensen, Sidsel
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Sperling, Bjorn
    NEUROLOGY AND THERAPY, 2024, 13 (02) : 339 - 353
  • [2] Eptinezumab demonstrated efficacy regardless of prior preventive migraine treatment failure: Post hoc DELIVER analyses
    Pozo-Rosich, Patricia
    Ashina, Messoud
    Tepper, Stewart J.
    Jensen, Sidsel
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Sperling, Bjorn
    CEPHALALGIA, 2023, 43 (1supp) : 227 - 227
  • [3] Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial
    Ashina, Messoud
    Lipton, Richard B.
    Ailani, Jessica
    Versijpt, Jan
    Sacco, Simona
    Mitsikostas, Dimos D.
    Christoffersen, Cecilie Laurberg
    Sperling, Bjorn
    Ettrup, Anders
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (02)
  • [4] Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
    Ashina, Messoud
    Lanteri-Minet, Michel
    Ettrup, Anders
    Christoffersen, Cecilie Laurberg
    Josiassen, Mette Krog
    Phul, Ravinder
    Sperling, Bjorn
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (05)
  • [5] Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
    Gryglas-Dworak, Anna
    Schim, Jack
    Ettrup, Anders
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Ranc, Kristina
    Sperling, Bjrn
    Ashina, Messoud
    HEADACHE, 2025, 65 (01): : 101 - 112
  • [6] Change in Migraine Diagnosis After Preventive Treatment With Eptinezumab: Post Hoc Analysis of the PROMISE Studies
    Pozo-Rosich, P.
    Dodick, D.
    Ettrup, A.
    Hirman, J.
    Cady, R.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [7] Change in migraine diagnosis after preventive treatment with eptinezumab: Post hoc analysis of the PROMISE studies
    Pozo-Rosich, P.
    Dodick, D. W.
    Ettrup, A.
    Hirman, J.
    Cady, R.
    HEADACHE, 2022, 62 : 134 - 134
  • [8] Change in Migraine Diagnosis After Preventive Treatment with Eptinezumab: Post Hoc Analysis of the PROMISE Studies
    Cady, Roger
    Pozo-Rosich, Patricia
    Dodick, David
    Ettrup, Anders
    Hirman, Joe
    Asher, Divya
    ANNALS OF NEUROLOGY, 2022, 92 : S40 - S40
  • [9] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C. L.
    Josiassen, M. K.
    Phul, R.
    Sperling, B.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [10] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 418 - 418
12345